Fortress Biotech Stock Quote FBIO - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.4697

Bid

1.46

Ask

1.47

Volume

481,685

1.46 Day's Range 1.55

1.24 52 Week Range 5.2485

Market Cap

33.53M

Previous Close

1.495

Open

1.54

Last Trade

1.4691

Last Trade Time

12:52:53

Financial Volume

$ 718,468

VWAP

1.4916

Average Volume (3m)

362,103

Shares Outstanding

22,813,954

Dividend Yield

PE Ratio

-0.49

Earnings Per Share (EPS)

-3.01

Revenue

84.51M

Net Profit

-68.67M

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the g... Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.fortressbiotech.com

Headquarters

Dover, Delaware, USA

Founded

Fortress Biotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBIO. The last closing price for Fortress Biotech was $1.50. Over the last year, Fortress Biotech shares have traded in a share price range of $ 1.24 to $ 5.2485.

Fortress Biotech currently has 22,813,954 shares outstanding. The market capitalization of Fortress Biotech is $34.11 million. Fortress Biotech has a price to earnings ratio (PE ratio) of -0.49.

Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to...

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

SCOTTSDALE, Ariz., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.5153	-25.959697733	1.985	2.04	1.4201	1416309	1.5429643	CS
4	-0.6703	-31.3224299065	2.14	2.1599	1.4201	539668	1.65525791	CS
12	-0.2803	-16.0171428571	1.75	2.89	1.4201	362103	1.87317152	CS
26	-0.4503	-23.453125	1.92	2.89	1.4201	271646	1.8628482	CS
52	-3.0303	-67.34	4.5	5.2485	1.24	414728	2.25387677	CS
156	-48.6303	-97.0664670659	50.1	57.15	1.24	498511	14.28963421	CS
260	-22.5303	-93.87625	24	91.5	1.24	642021	34.99692353	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KAVLKaival Brands Innovations Group Inc	$ 1.4401 (148.72%)	153.99M
LASELaser Photonics Corporation	$ 17.423 (67.37%)	7.37M
TGLTreasure Global Inc	$ 1.12 (64.63%)	128.8M
NVVENuvve Holding Corporation	$ 5.89 (50.26%)	27.71M
UXINUxin Ltd	$ 2.37 (49.53%)	11.72M
ELABElevai Labs Inc	$ 0.1109 (-60.39%)	13.33M
ADTXAditxt Inc	$ 0.269 (-29.69%)	2.05M
FRGTFreight Technologies Inc	$ 0.0805 (-29.26%)	21.84M
ZJYLJin Medical International Ltd	$ 2.8901 (-29.16%)	726.53k
ANEBAnebulo Pharmaceuticals Inc	$ 2.34 (-24.03%)	89.04k
XPONExpion360 Inc	$ 0.107631 (26.92%)	364.45M
KAVLKaival Brands Innovations Group Inc	$ 1.4401 (148.72%)	153.99M
TGLTreasure Global Inc	$ 1.12 (64.63%)	128.8M
NVDANVIDIA Corporation	$ 115.56 (-0.38%)	119.51M
INTCIntel Corporation	$ 22.5499 (3.25%)	111.84M